CINECA IRIS Institutional Research Information System

MACCARIO, Mauro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.432
EU - Europa 5.394
AS - Asia 3.235
SA - Sud America 193
OC - Oceania 91
AF - Africa 51
Continente sconosciuto - Info sul continente non disponibili 4
Totale 16.400
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.222
CN - Cina 1.775
IT - Italia 1.056
SE - Svezia 763
DE - Germania 612
IE - Irlanda 608
UA - Ucraina 535
FR - Francia 412
GB - Regno Unito 371
FI - Finlandia 326
KR - Corea 322
SG - Singapore 321
CA - Canada 180
JP - Giappone 152
PL - Polonia 147
BR - Brasile 131
AT - Austria 124
VN - Vietnam 121
TR - Turchia 93
IN - India 87
AU - Australia 86
ES - Italia 82
HK - Hong Kong 69
GR - Grecia 60
NL - Olanda 57
RU - Federazione Russa 53
ID - Indonesia 51
TW - Taiwan 50
BE - Belgio 38
MY - Malesia 29
PH - Filippine 27
PT - Portogallo 27
RO - Romania 25
CH - Svizzera 24
MX - Messico 22
IL - Israele 21
JO - Giordania 20
MU - Mauritius 19
UZ - Uzbekistan 18
AR - Argentina 17
DK - Danimarca 17
NO - Norvegia 14
CL - Cile 12
BG - Bulgaria 10
CO - Colombia 10
IR - Iran 10
TH - Thailandia 9
CZ - Repubblica Ceca 8
PE - Perù 8
QA - Qatar 8
SN - Senegal 8
HU - Ungheria 7
PK - Pakistan 7
CY - Cipro 6
EC - Ecuador 6
ZA - Sudafrica 6
AF - Afghanistan, Repubblica islamica di 5
NZ - Nuova Zelanda 5
PY - Paraguay 5
BD - Bangladesh 4
EU - Europa 4
GT - Guatemala 4
KW - Kuwait 4
LB - Libano 4
NG - Nigeria 4
AE - Emirati Arabi Uniti 3
BA - Bosnia-Erzegovina 3
DZ - Algeria 3
EG - Egitto 3
IQ - Iraq 3
KZ - Kazakistan 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
CI - Costa d'Avorio 2
CR - Costa Rica 2
EE - Estonia 2
ET - Etiopia 2
LK - Sri Lanka 2
PR - Porto Rico 2
SA - Arabia Saudita 2
SI - Slovenia 2
UY - Uruguay 2
AL - Albania 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
GH - Ghana 1
KE - Kenya 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
MW - Malawi 1
PS - Palestinian Territory 1
RS - Serbia 1
UG - Uganda 1
VE - Venezuela 1
Totale 16.400
Salva come PNG Salva come JPEG
Città #
Beijing 1.374
Chandler 1.033
Dublin 593
Houston 557
Ashburn 309
Fairfield 288
Jacksonville 274
Ann Arbor 253
Singapore 226
Medford 221
Wilmington 203
Dearborn 199
Nyköping 199
Woodbridge 184
Princeton 181
Villeurbanne 180
Redwood City 179
Milan 176
Torino 140
Vienna 116
Warsaw 113
Seattle 103
Cambridge 96
Verona 82
Boardman 80
Boston 73
Dong Ket 71
Turin 69
Pisa 62
Toronto 61
Lachine 43
Guangzhou 41
Jakarta 41
Tokyo 40
Shanghai 39
Santa Clara 38
Munich 32
Norwalk 32
Brussels 31
Taipei 31
Pune 30
Nanjing 29
Fremont 28
Falls Church 27
New York 27
Hefei 26
Washington 26
Hangzhou 25
Ankara 24
London 24
Mountain View 24
Rome 24
São Paulo 24
Ottawa 21
Los Angeles 20
Chengdu 19
Kuala Lumpur 18
Padova 18
Helsinki 17
Moscow 17
Paris 17
Seoul 17
Central District 16
Cupertino 16
Delhi 15
Detroit 15
Istanbul 15
San Diego 15
Hong Kong 14
Absecon 13
Duncan 13
Hebei 13
San Mateo 13
Barcelona 12
Central 12
Düsseldorf 12
Berlin 11
Buenos Aires 11
Kunming 11
Menlo Park 11
Philadelphia 11
Piemonte 11
Portland 11
Wuhan 11
Chicago 10
Melbourne 10
Redmond 10
Silver Spring 10
Tappahannock 10
Alcalá De Henares 9
Athens 9
Napoli 9
Polska 9
Changsha 8
Figtree 8
Frankfurt am Main 8
Kiel 8
Montreal 8
Nanchang 8
Phoenix 8
Totale 8.989
Salva come PNG Salva come JPEG
Nome #
Is the timing of caloric intake associated with variation in diet-induced thermogenesis and in the metabolic pattern? A randomized cross-over study 2.442
Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes 432
CUSHING'S SYNDROME IS ASSOCIATED WITH SLEEP ALTERATIONS DETECTED BY WRIST ACTIGRAPHY 339
Italian Association of Clinical Endocrinologists (AME) & Italian Association of Clinical Diabetologists (AMD) Position Statement : Diabetes mellitus and thyroid disorders: recommendations for clinical practice. 322
Somatic ATP1A1, ATP2B3, and KCNJ5 Mutations in Aldosterone-Producing Adenomas 318
Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma. 309
Cardiovascular risk and metabolic syndrome in primary hyperparathyroidism and their correlation to different clinical forms. 285
Aldosterone suppression on contralateral adrenal during adrenal vein sampling does not predict blood pressure response after adrenalectomy. 268
Urinary cortisol and psychopathology in obese binge eating subjects. 243
Enhanced oxidative stress and platelet activation in patients with Cushing's syndrome. 231
Acylated ghrelin as a provocative test for the diagnosis of GH deficiency in adults. 194
Long-term re-evaluation of primary aldosteronism after medical treatment reveals high proportion of normal mineralocorticoid secretion. 188
HLA DRB1*0415: a new possible genetic susceptibility factor for Hirata's disease 186
Short-term fasting abolishes the sex-related difference in GH and leptin secretion in humans. 171
Mezzo di contrasto iodato e funzionalità tiroidea: una relazione da non sottovalutare. 160
Effects of meal timing on changes in circulating epinephrine, norepinephrine, and acylated ghrelin concentrations: A pilot study 152
PERCORSO DIAGNOSTICOTERAPEUTICO ASSISTENZIALE DELLE MALATTIE TIROIDEE 135
Effects of free fatty acids and acipimox, a lipolysis inhibitor, on the somatotroph responsiveness to GHRH in anorexia nervosa. 131
Arginine potentiates but does not restore the blunted growth hormone response to growth hormone-releasing hormone in obesity. 127
Arginine reinstates the somatotrope responsiveness to intermittent growth hormone-releasing hormone administration in normal adults. 124
Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans. 122
Interactions of galanin and arginine on growth hormone, prolactin, and insulin secretion in man. 117
Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 11 Medical and Health Sciences 1103 Clinical Sciences 117
Diagnosis of GH deficiency in adults. 113
68 Ga-DOTA-TOC PET/CT of von Hippel-Lindau Disease 108
Adrenalectomy Lowers Incident Atrial Fibrillation in Primary Aldosteronism Patients at Long Term 105
GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism. 104
Blunted GH response to growth hormone-releasing hormone (GHRH) alone or combined with arginine in non-insulin-dependent diabetes mellitus. 104
Pirenzepine decreases basal and stimulated GH secretion in patients with type 2 (non-insulin-dependent) diabetes mellitus. 104
Repeated administration of growth hormone-releasing hormone with or without previous administration of pyridostigmine in insulin-dependent diabetes mellitus. 103
Adrenal responsiveness to high, low and very low ACTH 1-24 doses in obesity. 103
Management of renal cancer in a contemporary series of patients affected by Von Hippel-Lindau disease. 103
Inhibition by salbutamol of GHRH-induced GH release in type 1 diabetes mellitus. 101
Differential expressed proteins in urine samples from Von Hippel-Lindau disease and renal cell carcinoma patients versus healthy people. 101
[Neuroregulation of GH secretion in aging] 99
The GH/IGF-I axis in obesity: influence of neuro-endocrine and metabolic factors. 97
Comparison of Monotard and Ultratard insulin at bedtime in a model of optimized insulin therapy in Italy. 97
Effects of alprazolam, a benzodiazepine, on the ACTH-, GH- and PRL-releasing activity of hexarelin, a synthetic peptidyl GH secretagogue (GHS), in patients with simple obesity and in patients with Cushing's disease. 95
Comparison of the potentiating effect of pyridostigmine, arginine and propranolol on the GHRH-induced GH release in short children. 94
Repetitive GHRH administration fails to increase the response to GHRH in obese subjects. Evidence for a somatotrope defect in obesity? 93
HYPERCORTISOLISM DUE TO CUSHING’S DISEASE IS ASSOCIATED TO DERANGED GHRELIN SECRETION AND ACTION 93
Somatotrope responsiveness to Hexarelin, a synthetic hexapeptide, is refractory to the inhibitory effect of glucose in obesity. 92
Metabolic modulation of the growth hormone-releasing activity of hexarelin in man. 88
Acylated ghrelin as provocative test for the diagnosis of ACTH deficiency in patients with hypothalamus–pituitary disease 86
Concomitant impairment of GH secretion and peripheral sensitivity in obese patients with obstructive sleep apnea syndrome 86
Effects of direct and indirect acetylcholine receptor agonists on growth hormone secretion in humans. 85
The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism 85
Ageing, growth hormone and physical performance. 84
ADRENAL SENSITIVITY TO ACTH1-24 AS FUNCTION OF AGE, BODY WEIGHT AND PITUITARY FUNCTION 84
Dose-response study of GH effects on circulating IGF-I and IGFBP-3 levels in healthy young men and women. 83
Interaction of free fatty acids and arginine on growth hormone secretion in man. 83
Biologic activities of growth hormone secretagogues in humans. 83
Pathophysiological doses of glucagon cause a transient increase of the hepatic vein potassium concentration in man. 82
SENSITIVITY AND SPECIFICITY OF DIFFERENT PROVOCATIVE TESTS ASSESSING THE FUNCTION OF HYPOTHALAMO-PITUITARY-ADRENAL (HPA) AXIS IN PATIENTS SUSPECTED FOR SECONDARY HYPOADRENALISM 82
Radiofrequency ablation for thyroid nodules: which indications? The first Italian opinion statement 82
Pituitary-gonadal function in males with Down’s syndrome. 82
Interaction of salbutamol with pyridostigmine and arginine on both basal and GHRH-stimulated GH secretion in humans. 81
A multicenter epidemiological study on second malignancy in non-syndromic pheochromocytoma/paraganglioma patients in Italy 81
Effects of chronic slow release-lanreotide treatment on insulin-like growth factor system and metabolic parameters in acromegalic patients 80
ADRENAL SENSITIVITY TO ACTH1-24 AS FUNCTION OF AGE, BODY WEIGHT AND PITUITARY FUNCTION 80
Progression of pituitary tumours: impact of GH secretory status and long-term GH replacement therapy 80
Three-month treatment with metformin or dexfenfluramine does not modify the effects of diet on anthropometric and endocrine-metabolic parameters in abdominal obesity. 80
GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism. 79
Alprazolam, a benzodiazepine, blunts but does not abolish the ACTH and cortisol response to hexarelin, a GHRP, in obese patients. 79
DIFFERENT ENDOCRINE-METABOLIC ABNORMALITIES BETWEEN “PURE” 45,XO TURNER’S SYNDROME AND MOSAICS 79
Maximal secretory capacity of somatotrope cells in obesity: comparison with GH deficiency. 79
Interaction of salbutamol and galanin on both basal and growth hormone releasing hormone-stimulated growth hormone secretion in humans. 78
Assessment of GH/IGF-I axis in obesity by evaluation of IGF-I levels and the GH response to GHRH+arginine test. 77
Age-related endocrine and metabolic changes in simple obesity. 77
Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients 76
Retrospective observational analysis of non-irradiated non-functioning pituitary adenomas 74
ADULT PATIENTS WITH DOWN’S SYNDROME SHOW ENHANCED BASAL TSH LEVELS BUT NORMAL TSH RESPONSE TO TRH 73
Association of Urine Metanephrine Levels with Cardiometabolic Risk: An Observational Retrospective Study 73
[Growth hormone and lipids] 72
Chronic treatment with pirenzepine decreases growth hormone secretion in insulin-dependent diabetes mellitus. 71
Untreated adult GH deficiency is not associated with the development of metabolic risk factors: a long-term observational study 71
Pirenzepine blunts the nocturnal growth hormone release in insulin dependent diabetes. 70
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients 69
Development and internal validation of a predictive model for the estimation of pheochromocytoma recurrence risk after radical surgery 68
Comparisons among old and new provocative tests of GH secretion in 178 normal adults. 67
Diagnostica neuroendocrina del paziente obeso (alterazioni neuroendocrine nel paziente obeso) 67
The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index 67
The inhibitory effect of glucose on growth hormone secretion is lost in obesity but not in hypertension. 66
Effect of arginine and pyridostigmine on the GHRH-induced GH rise in obesity and Cushing's syndrome. 66
Low dose orally administered arginine is able to enhance both basLow dose orally administered arginine is able to enhance both basal and growth hormone-releasing hormone-induced growth hormone secretion in normal short children. 66
Treating with liraglutide an obese patient with type 2 diabetes mellitus and hereditary hemochromatosis 66
Use of the Diabetes Risk Score for Opportunistic Screening of Undiagnosed Diabetes and Impaired Glucose Tolerance: The IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study 66
Incidenza di alterazioni tiroidee dopo coronarografia con mezzo di contrasto iodato. 66
L-Arginine 65
Long-term morphological, hormonal and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas 64
ENDOCRINE DISORDERS 64
Predictor Analysis in Radiofrequency Ablation of Benign Thyroid Nodules: A Single Center Experience 64
From SGAP-Model to SGAP-Score: A Simplified Predictive Tool for Post-Surgical Recurrence of Pheochromocytoma 63
METABOLIC AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT AETIOLOGY DURING ACTIVE DISEASE AND 1 YEAR AFTER REMISSION 63
Obstructive sleep apnea syndrome impairs insulin sensitivity independently of anthropometric variables 61
Effects of glucose, free fatty acids or arginine load on the GH-releasing activity of ghrelin in humans. 61
Control and function of the GH-IGF-I axis in obesity. 60
Obese patients with obstructive sleep apnoea syndrome show a peculiar alteration of the corticotroph but not of the tyhrotroph and lactotroph function 60
Relationships between IGF-I and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients. 60
Ghrelin and other gastrointestinal peptides involved in the control of food intake 60
Totale 13.286
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.325
article - articoli 0
book - libri 0
conference - conferenze 3.558
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.883
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.259 0 0 183 219 251 533 239 161 238 177 164 94
2020/20211.961 146 117 177 100 242 125 176 102 222 192 129 233
2021/20221.923 70 87 101 106 116 92 142 119 99 224 327 440
2022/20233.091 338 217 67 347 312 741 229 188 328 74 148 102
2023/20241.536 196 241 93 105 150 200 58 104 15 79 98 197
2024/2025378 68 211 99 0 0 0 0 0 0 0 0 0
Totale 16.961